TABLE 3.
Risk factors for hospital admission for bacterial foodborne infection
| OR (95% CI) | p | Adjusted OR (95% CI) | p | |
|---|---|---|---|---|
| Age at infection | 0.98 (0.96–1.00) | 0.078 | 0.98 (0.96–1.00) | 0.108 |
| Sex (F) | 0.78 (0.39–1.59) | 0.500 | 0.67 (0.32–1.44) | 0.307 |
| Years after transplantation | 1.32 (1.08–1.61) | 0.007 | 1.35 (1.11–1.66) | 0.003 |
| Transplanted organ | ||||
| Kidney | 0.48 (0.24–0.99) | 0.046 | 0.53 (0.25–1.13) | 0.099 |
| Liver | 1.44 (0.53–3.89) | 0.471 | ||
| Heart | 2.13 (0.68–6.70) | 0.196 | ||
| Lung | 2.89 (0.54–15.41) | 0.214 | ||
| Salmonella infection | 1.29 (0.44–3.77) | 0.639 | ||
| Maintenance immunosuppression a | ||||
| Tacrolimus | 0.54 (0.24–1.21) | 0.133 | ||
| Mycophenolate (MMF or MPA) | 0.42 (0.13–1.28) | 0.127 | ||
| Prednisone | 0.56 (0.26–1.21) | 0.139 | ||
| TMP‐SMX prophylaxis a | 0.81 (0.39–1.68) | 0.577 | ||
| Acute rejection b | 0.87 (0.22–3.39) | 0.846 |
Hospital admission was unknown in six episodes.
Abbreviations: CI, confidence interval; F, female; MMF, mycophenolate mofetil; MPA, mycophenolic acid; OR, odds ratio; TMP‐SMX, trimethoprim‐sulfamethoxazole.
a
At time of infection.
b
Treated acute rejection within 180 days before infection.